Mark Rothera
Directeur Général chez VIRACTA THERAPEUTICS, INC.
Fortune : - $ au 31/05/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Frank Thomas | M | 54 |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom.
Orchard Therapeutics North America
 Orchard Therapeutics North America BiotechnologyHealth Technology Part of Orchard Therapeutics Plc, Orchard Therapeutics North America provides biotechnology research services. The company is based in Boston, MA. The CEO of the company is Bobby Gaspar. | 6 ans |
| Craig Tooman | M | 58 | 3 ans | |
| Ivor Royston | M | 79 | 17 ans | |
| Roger Pomerantz | M | 67 | 4 ans | |
| Melody Burcar | F | 41 | 2 ans | |
| Karim Smaira | M | - |
Genpharm Services
 Genpharm Services Advertising/Marketing ServicesCommercial Services Genpharm Services operates as a pharmaceutical company providing partners with market access and commercial solutions into the Middle East and North Africa region. It also acts as a commercial partner for rare genetic diseases, orphan drugs, and specialty therapeutics and offers strategic advice on disease areas, product launches and go-to markets strategies. The company was founded by Karim Smaira and Kamel Ghammachi in 2012 and is headquartered in Dubai, United Arab Emirates. | 12 ans |
| Jon Ellis | M | 57 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 ans |
| Joanne Beck | M | 63 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 ans |
| Simone Song | F | 59 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 7 ans |
| James Geraghty | M | 69 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 ans |
| Jane Barlow | M | 63 | 3 ans | |
| Glenn Steele | M | 79 | 9 ans | |
| Jane Chung | F | 53 | 2 ans | |
| Eric Pauwels | M | 63 |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 15 ans |
| Kamel Ghammachi | M | - |
Genpharm Services
Genpharm Services Advertising/Marketing ServicesCommercial Services Genpharm Services operates as a pharmaceutical company providing partners with market access and commercial solutions into the Middle East and North Africa region. It also acts as a commercial partner for rare genetic diseases, orphan drugs, and specialty therapeutics and offers strategic advice on disease areas, product launches and go-to markets strategies. The company was founded by Karim Smaira and Kamel Ghammachi in 2012 and is headquartered in Dubai, United Arab Emirates. | 12 ans |
| Sam Murphy | M | 47 | 5 ans | |
| Stephen Rubino | M | 65 | 3 ans | |
| Rhonda L. Hellums | F | 52 | 3 ans | |
| Charles Rowland | M | 65 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 ans |
| Marc Dunoyer | M | 71 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | 6 ans |
| Barry Simon | M | 59 | 3 ans | |
| Flavia Borellini | M | 65 | 3 ans | |
| Bobby Gaspar | M | 60 |
Orchard Therapeutics North America
Orchard Therapeutics North America BiotechnologyHealth Technology Part of Orchard Therapeutics Plc, Orchard Therapeutics North America provides biotechnology research services. The company is based in Boston, MA. The CEO of the company is Bobby Gaspar. | 6 ans |
| Ashleigh Barreto | F | - | 3 ans | |
| Martin Rexroad | M | - | 11 ans | |
| Thomas Darcy | M | 74 | 3 ans | |
| Biljana Nadjsombati | F | - | 3 ans | |
| Donald Strickland | M | - | - | |
| Darrel Cohen | M | 59 | 1 ans | |
| Ashkar Samy | M | - |
Genpharm Services
Genpharm Services Advertising/Marketing ServicesCommercial Services Genpharm Services operates as a pharmaceutical company providing partners with market access and commercial solutions into the Middle East and North Africa region. It also acts as a commercial partner for rare genetic diseases, orphan drugs, and specialty therapeutics and offers strategic advice on disease areas, product launches and go-to markets strategies. The company was founded by Karim Smaira and Kamel Ghammachi in 2012 and is headquartered in Dubai, United Arab Emirates. | - |
| Michael Davidson | M | 67 | 3 ans | |
| Patric Nelson | M | - | 3 ans | |
| Ayman El-Guindy | M | - | 3 ans | |
| Elmar Schnee | M | 65 |
Genpharm Services
Genpharm Services Advertising/Marketing ServicesCommercial Services Genpharm Services operates as a pharmaceutical company providing partners with market access and commercial solutions into the Middle East and North Africa region. It also acts as a commercial partner for rare genetic diseases, orphan drugs, and specialty therapeutics and offers strategic advice on disease areas, product launches and go-to markets strategies. The company was founded by Karim Smaira and Kamel Ghammachi in 2012 and is headquartered in Dubai, United Arab Emirates. | - |
| Stewart M. Brown | M | - | 2 ans | |
| Cheryl A. Madsen | F | - | - | |
| Murad Husain | M | - | 10 ans | |
| Curtis Rambaran | M | - | 3 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Daniel Chevallard | M | 44 | 5 ans | |
| Marcio Souza | M | 45 | 6 ans | |
| Ben Harshbarger | M | 55 | 4 ans | |
| Benjamin Auspitz | M | 51 |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | - |
| Alicia Secor | F | 62 | 6 ans | |
| Nicolas Koebel | M | - | - | |
| Dawn Svoronos | F | 70 | 6 ans | |
| Megan Sniecinski | F | 43 | 5 ans | |
| Kurt J. W. Andrews | M | 54 | 9 ans | |
| John Curnutte | M | 72 | 5 ans | |
| Stephen J. Moloney | M | - |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 9 ans |
| Cláudia Hirawat | F | 53 | 15 ans | |
| Emily Hill | F | 44 | - | |
| Alexander Pasteur | M | 54 | - | |
| William T. Andrews | M | 60 | 4 ans | |
| Robert Quinn | M | 41 | 4 ans | |
| Adam Koppel | M | 54 | 4 ans | |
| Steven Altschuler | M | 70 | 4 ans | |
| Suzanne Bruhn | M | 60 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 14 ans |
| Michael L. Kranda | M | 69 | 12 ans | |
| Richard H. Aldrich | M | 69 | 2 ans | |
| Axel Bolte | M | 52 | 11 ans | |
| Ronald Renaud | M | 55 | 3 ans | |
| Nicole Onetto | M | 71 | 2 ans | |
| Elise T. Wang | F | 64 | - | |
| Shelly Vandertie | F | - | - | |
| Alyssa Wyant | F | 49 | 2 ans | |
| Justine O'Malley | M | - | - | |
| Tu Yen Ong | M | 49 | - | |
| Edward O'Mara | M | - | 4 ans | |
| Anne Marie Conway | F | - |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 5 ans |
| Jason Meyenburg | M | 47 | 1 ans | |
| Andrew Komjathy | M | 61 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 7 ans |
| Morgan Conn | M | 42 | 16 ans | |
| Anjana Harve | F | - |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 2 ans |
| Sachiyo Minegishi | F | 46 | 4 ans | |
| Frank DeRosa | M | - |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 7 ans |
| Ran Zheng | F | 61 | 2 ans | |
| Stephen Dilly | M | 64 |
CHIRON Biopharmaceuticals
| 3 ans |
| Nancy M. Wyant | F | - |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 6 ans |
| Moya M. Daniels | F | 55 | 2 ans | |
| Adrian Haigh | M | 65 | 8 ans | |
| Sylvie Grégoire | M | 62 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 6 ans |
| Craig Wheeler | M | 63 |
CHIRON Biopharmaceuticals
| 5 ans |
| Paul Hastings | M | 64 |
CHIRON Biopharmaceuticals
| 10 ans |
| Stewart Craig | M | 63 | 3 ans | |
| Peter Svennilson | M | 62 | 2 ans | |
| Scott Wilhoit | M | 61 | 1 ans | |
| Deanna M. Petersen | F | 62 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 6 ans |
| Robert Spiegel | M | 73 | 5 ans | |
| Susan E. Barrowcliffe | F | 66 |
CHIRON Biopharmaceuticals
| 2 ans |
| James G. Stout | M | 58 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 2 ans |
| Jay Barth | M | 60 | 5 ans | |
| Amanda Cray | F | - | 7 ans | |
| Lisa Rojkjaer | M | 58 | 3 ans | |
| Massimo Boriero | M | - | - | |
| Daniel van Plew | M | 51 |
CHIRON Biopharmaceuticals
| 2 ans |
| Shane Kovacs | M | 50 | - | |
| Theresa Heggie | F | 63 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 3 ans |
| R. Session | M | 45 | 4 ans | |
| Sue Cammarata | M | 67 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 3 ans |
| Tom Luby | M | - |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | 3 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 74 | 74,00% |
| Royaume-Uni | 24 | 24,00% |
| Emirats Arabes Unis | 4 | 4,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Mark Rothera
- Réseau Personnel
